Anxo Pharmaceutical Co., Ltd. carries a market capitalization of 957.26M, placing it among publicly traded companies globally.
| Market Cap | 957.26M |
| Enterprise Value | N/A |
Anxo Pharmaceutical Co., Ltd.'s stock has declined approximately -0.29154519% over the past 52 weeks. The 50-day moving average sits at 17.83, while the 200-day moving average is 20.42.
| Beta (5Y) | N/A |
| 52-Week Price Change | -0.29154519% |
| 50-Day Moving Average | 17.83 |
| 200-Day Moving Average | 20.42 |
| Average Volume (20 Days) | N/A |
Anxo Pharmaceutical Co., Ltd.'s most recent stock split took place on July 11, 2023 with a 250:259 split ratio.
| Last Split Date | 7/11/2023 |
| Split Ratio | 250:259 |